Skip to main content
. 2018 Feb 16;9:74. doi: 10.3389/fneur.2018.00074

Table 3.

c-Statistics of the RICH, MSS, and THRIVE scores for risk of symptomatic intracranial hemorrhage (sICH) after systemic thrombolytic therapy for acute ischemic stroke in the validation cohort (Basel, n = 983).

Score sICH per ECASS-IIIa
RICH (n = 983) 0.69 (0.60–0.77)
MSS (n = 969) 0.66 (0.52–0.70)
THRIVE (n = 979) 0.67 (0.59–0.76)

ac-Statistics (95% CI).